AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
Healthcare
$7.25 +0.10%
+$0.01 today
- Market cap
- $989.81M
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
52W Low $8.06High $13.43
Volume 1.71M
Average 1.38M
Income Statement
Follow revenue through to earnings.
Revenue
$3.24B
FY 2025 · Annual
-0.5% YoYOperating Income
$186.27M
FY 2025 · Annual
-29.4% YoYNet Income
-$70.79M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.45B | 2.97B | 3.2B | 3.26B | 3.24B |
| Cost of Revenue | 2.01B | 2.55B | 2.52B | 2.58B | 2.68B |
| Gross Profit | 445.61M | 417.43M | 681.77M | 681.09M | 568.56M |
| Gross Margin | 18.2% | 14.1% | 21.3% | 20.9% | 17.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 167.51M | 162.13M | 190.09M | 359.24M | 382.29M |
| Operating Expenses | 220.01M | 227.02M | 1.28B | 417.36M | 382.29M |
| Depreciation & Amortization | 258.05M | 423.44M | 420.59M | 365.33M | 413.04M |
| EBITDA | 544.21M | 630.76M | (171.09M) | 628.02M | 503.64M |
| EBITDA Margin | 22.2% | 21.2% | -5.3% | 19.3% | 15.5% |
| Operating Income | 225.61M | 190.41M | (598.4M) | 263.73M | 186.27M |
| Operating Margin | 9.2% | 6.4% | -18.7% | 8.1% | 5.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.2M | 109.41M | 130.3M | 126.67M | 105.75M |
| Other Income / Expenses | (34.65M) | (92.51M) | (125.38M) | (127.71M) | (201.42M) |
| Income Before Tax | 190.96M | 97.9M | (723.78M) | 136.02M | (15.15M) |
| Pre-Tax Margin | 7.8% | 3.3% | -22.6% | 4.2% | -0.5% |
| Income Tax Expense | 32.81M | 24.77M | (49M) | 41.24M | 50.88M |
| Net Income | 156.18M | 69.32M | (678.9M) | 90.42M | (70.79M) |
| Net Margin | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
| EPS (Basic) | 1.12 | 0.52 | (5.32) | 0.62 | (0.52) |
| EPS (Diluted) | 0.67 | 0.50 | (5.31) | 0.61 | (0.52) |
| 126.31M | 134.18M | 134.16M | 133.76M | 135.15M | |
| 133.03M | 138.99M | 134.42M | 135.53M | 135.15M |
AHCO Earnings Waterfall · TTM
NASDAQ:AHCO · Revenue to Net Income
Key Ratios
EPS$-0.59
Gross Margin3.3%
Net Margin-1.9%
P/E Ratio1.3
P/S Ratio1.9
Analysis
$2.9B of revenue converted into -$79.6M of net income for the selected period. Gross margin is 3.3% and net margin is -1.9%, showing how much revenue survives after costs and taxes. EPS is $-0.59, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 10-Q | Quarterly report | Nov 3, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 8, 2026 |
How much revenue does AHCO generate?
AdaptHealth Corp. (AHCO) reported $3.24B of revenue in fiscal 2025.
Is AHCO profitable?
AdaptHealth Corp. (AHCO) reported -$70.79M of net income, with a net margin of -2.2%.
Continue the stock analysis
Jump to another research area for this company.